L. Roy Papp & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
8,457
-369
-4% -$43.2K 0.11% 92
2026
Q1
$1.06M Buy
8,826
+52
+0.6% +$6K 0.12% 95
2025
Q4
$924K Buy
8,774
+428
+5% +$40.2K 0.1% 100
2025
Q3
$700K Sell
8,346
-583
-7% -$48K 0.08% 109
2025
Q2
$707K Buy
8,929
+1
+0% +$79 0.08% 103
2025
Q1
$801K Sell
8,928
-89
-1% -$8.31K 0.1% 100
2024
Q4
$897K Buy
9,017
+1
+0% +$103 0.1% 100
2024
Q3
$1.02M Hold
9,016
0.12% 94
2024
Q2
$1.12M Buy
9,016
+1
+0% +$129 0.14% 88
2024
Q1
$1.19M Sell
9,015
-333
-4% -$41K 0.14% 90
2023
Q4
$1.02M Sell
9,348
-149
-2% -$15.5K 0.13% 94
2023
Q3
$978K Buy
9,497
+21
+0.2% +$2.26K 0.13% 95
2023
Q2
$1.09M Buy
9,476
+237
+3% +$26.9K 0.14% 90
2023
Q1
$983K Sell
9,239
-229
-2% -$24.7K 0.13% 94
2022
Q4
$1.05M Sell
9,468
-403
-4% -$41.2K 0.15% 91
2022
Q3
$850K Buy
9,871
+101
+1% +$9.02K 0.13% 98
2022
Q2
$891K Buy
9,770
+138
+1% +$12.2K 0.13% 103
2022
Q1
$790K Sell
9,632
-29
-0.3% -$2.29K 0.1% 110
2021
Q4
$740K Buy
9,661
+1
+0% +$80 0.08% 116
2021
Q3
$726K Sell
9,660
-399
-4% -$30.3K 0.09% 113
2021
Q2
$782K Buy
10,059
+425
+4% +$31.6K 0.1% 109
2021
Q1
$709K Sell
9,634
-3,239
-25% -$239K 0.1% 108
2020
Q4
$1M Buy
12,873
+1
+0% +$76 0.12% 98
2020
Q3
$1.02M Buy
12,872
+2,024
+19% +$159K 0.13% 93
2020
Q2
$800K Buy
10,848
+132
+1% +$9.94K 0.11% 99
2020
Q1
$787K Buy
10,716
+735
+7% +$57.8K 0.14% 98
2019
Q4
$866K Buy
9,981
+114
+1% +$9.36K 0.12% 104
2019
Q3
$793K Sell
9,867
-367
-4% -$29.4K 0.12% 107
2019
Q2
$819K Buy
10,234
+1
+0% +$77 0.13% 103
2019
Q1
$812K Sell
10,233
-2,985
-23% -$223K 0.15% 91
2018
Q4
$964K Sell
13,218
-424
-3% -$29.9K 0.2% 83
2018
Q3
$923K Sell
13,642
-138
-1% -$8.79K 0.16% 89
2018
Q2
$798K Sell
13,780
-3,219
-19% -$182K 0.15% 95
2018
Q1
$884K Buy
16,999
+4,902
+41% +$265K 0.17% 92
2017
Q4
$650K Buy
12,097
+458
+4% +$25.4K 0.13% 101
2017
Q3
$711K Buy
11,639
+41
+0.4% +$2.49K 0.15% 88
2017
Q2
$709K Sell
11,598
-2,305
-17% -$140K 0.15% 92
2017
Q1
$843K Sell
13,903
-208
-1% -$12.6K 0.19% 81
2016
Q4
$793K Hold
14,111
0.18% 90
2016
Q3
$840K Buy
14,111
+1
+0% +$58 0.19% 84
2016
Q2
$776K Hold
14,110
0.18% 94
2016
Q1
$712K Buy
14,110
+513
+4% +$25.1K 0.17% 95
2015
Q4
$685K Buy
13,597
+116
+0.9% +$5.85K 0.17% 91
2015
Q3
$635K Buy
13,481
+1,692
+14% +$89.9K 0.16% 94
2015
Q2
$640K Buy
11,789
+16
+0.1% +$897 0.15% 94
2015
Q1
$646K Buy
11,773
+100
+0.9% +$5.66K 0.14% 99
2014
Q4
$633K Hold
11,673
0.14% 97
2014
Q3
$660K Hold
11,673
0.15% 93
2014
Q2
$644K Hold
11,673
0.14% 95
2014
Q1
$632K Sell
11,673
-262
-2% -$13.6K 0.15% 92
2013
Q4
$570K Sell
11,935
-262
-2% -$12K 0.12% 95
2013
Q3
$554K Buy
12,197
+1,992
+20% +$90.9K 0.13% 91
2013
Q2
$452K Buy
+10,205
New +$456K 0.11% 98

Other funds holding MRK

L. Roy Papp & Associates's MRK Position: Q2 2026 in Review

L. Roy Papp & Associates reduced its Merck (MRK) stake by 4.2% in Q2 2026, selling an estimated $43.2K and leaving 8,457 shares worth $1.09M. The position accounts for 0.11% of the portfolio, ranked #92.

L. Roy Papp & Associates first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.19M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • L. Roy Papp & Associates held 8,457 shares of Merck worth $1.09M as of Q2 2026.
  • L. Roy Papp & Associates sold 369 Merck shares in Q2 2026, an estimated $43.2K.
  • Merck made up 0.11% of L. Roy Papp & Associates's portfolio in Q2 2026, its #92 holding.
  • L. Roy Papp & Associates first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • L. Roy Papp & Associates's Merck position peaked at $1.19M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.